Loading...
NPI 1942226006 · Springfield, MA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
System Coordinated Services, Inc is a clinical medical laboratory provider located in Springfield, Massachusetts. This profile covers 245 Medicare and 271 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | System Coordinated Services, Inc |
| Address | 299 Carew St |
| City | Springfield |
| State | MA |
| ZIP | 01104 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 14, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $18.5M |
| Medicare | $2.1M |
Payer mix is heavily skewed toward Medicaid: lifetime Medicaid revenue is $18.5M versus Medicare revenue of $2.1M, so the provider’s volume and commercial relationship profile are driven primarily by Medicaid business rather than Medicare. This scale difference suggests contracts, client base, and testing programs are concentrated in the state Medicaid market rather than in traditional Medicare referral streams.
Operating as a Clinical Medical Laboratory, the provider’s Medicare code mix is dominated by phlebotomy and routine chemistry/hematology panels and analytes: 36415 (venipuncture) alone accounts for 18.3% of Medicare revenue and the precomputed top-3 Medicare codes account for 35.6% of total Medicare revenue. The prominence of codes such as 80053, 80061, 84443 and 85025 indicates a high-throughput, specimen-collection-centered operation that processes large volumes of routine outpatient lab testing.
Medicare concentration is pronounced and concentrated in a few high-volume services: the top 3 Medicare codes drive 35.6% of Medicare revenue, with 36415 singled out as an "extreme outlier" nationally (ranks #82 of 86467). Several other routine panels and common analytes (80048, 80053, 80061, 84443) also sit at very high national percentiles, indicating this provider performs far more specimen-collection and routine panel work per Medicare beneficiary than typical peers.
On the Medicaid side the provider shows particularly strong market share for infectious disease and sexual health testing: 87590 (gonorrhea) and 87490 (chlamydia) each generate roughly $963.8K and $808.5K respectively and both rank #1 in-state (100th percentile; described as "notably above typical state volume"). The precomputed top-3 Medicaid codes account for 24.2% of Medicaid revenue, and U0003 (SARS‑CoV‑2 high-throughput testing) contributes $1M (8.9%)—together these patterns point to a large-volume, state-focused STI and high-throughput molecular testing footprint.
Competitive standing differs by payer: for Medicare the provider has national outlier status on core operational codes (e.g., 36415 is an "extreme outlier" and 80048 is also labeled an "extreme outlier"), which signals unusually high national-level activity for specimen collection and routine chemistry. For Medicaid the provider is a dominant in-state player for multiple diagnostic targets (87590 and 87490 are ranked #1 in-state and several other codes like 87502 and 87651 are at or above the 99th percentile), indicating market leadership in Massachusetts for selected infectious-disease and respiratory panels.
The code mix and high absolute claim counts for Medicaid (large claim volumes for 85025, 80050, 83036, 80061 and 80053) suggest the laboratory supports broad population-level screening as well as targeted STI and respiratory diagnostics. High counts for both routine panels and high-throughput molecular assays (U0003, 87502, 87635) imply a diversified technical platform capable of both automated chemistry/hematology and molecular diagnostics.
The provider’s Medicare business is more concentrated in its top services than its Medicaid business: top-3 Medicare codes represent 35.6% of Medicare revenue, while the top-3 Medicaid codes represent 24.2% of Medicaid revenue. This difference means Medicare revenue is more dependent on a few high-volume clinical workflows (notably venipuncture and select panels) while Medicaid revenue is spread across a broader set of testing services, including large-volume STI and public-health-related assays.
NPI tenure indicates long-standing operations: the NPI was enumerated on 2006-07-14 (~20 years ago), consistent with an established laboratory presence. Combined with the high volumes and top-state rankings for several Medicaid codes, the longevity supports a picture of an established, high-throughput clinical lab focused on state Medicaid and public-health testing programs.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
245 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 37,640 | $10 | $301.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 14,800 | $10 | $148K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 10,520 | $10 | $136.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 8,210 | $20 | $131.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 14,980 | $10 | $119.9K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 14,260 | $10 | $114K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 9,610 | $10 | $96.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 3,260 | $30 | $94.6K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 9,240 | $10 | $55.4K |
| 87077 | The lab analyst performs additional tests on a presumptively identified aerobic isolate to definitively, which means more specifically, identify the organism, such as to the level of species. | 6,880 | $10 | $55K |
Showing 1–10 of 245
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 245 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
245 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| P9603 | 3 | 10 | 38,630 | $1 | $294.6K |
| 87088 | 4 | 10 | 7,290 | $10 | $123.3K |
| 83921 | 4 | 10 | 1,280 | $20 | $122.5K |
| G0480 | 8 | 50 | 130 | $110 | $105.4K |
| 83090 | 4 | 10 | 2,000 | $20 | $94.9K |
| G0471 | 2 | 10 | 7,980 | $10 | $80.4K |
| 83520 | 5 | 10 | 2,590 | $20 | $74.7K |
| 82172 | 4 | 10 | 1,810 | $20 | $55.8K |
| 83525 | 5 | 10 | 1,360 | $10 | $51.7K |
| 86235 | 4 | 10 | 100 | $20 | $50.7K |
Showing 1–10 of 245
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
271 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 16,740 | $60 | $1M |
| 87590 | The lab analyst performs a test for Neisseria gonorrhoeae, a bacteria, using direct nucleic acid probe technique. | 48,190 | $20 | $963.8K |
| 87490 | The lab analyst performs a test for Chlamydia trachomatis using direct nucleic acid probe technique. Chlamydia trachomatis causes a common sexually transmitted disease and certain eye infections. | 44,920 | $20 | $808.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 39,960 | $20 | $719.2K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 29,900 | $20 | $627.8K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 72,780 | $10 | $582.2K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 32,680 | $20 | $555.5K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 136,490 | $1 | $545.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 14,020 | $40 | $532.6K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 100,030 | $10 | $500.2K |
Showing 1–10 of 271
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
271 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 16 | 20 | 310 | $260 | $2.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 21 | 130 | 1,830 | $60 | $974.3K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 9 | 30 | 270 | $290 | $731.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 58 | 370 | 500 | $40 | $605.1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 22 | 30 | 1,140 | $60 | $598K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 44 | 200 | 450 | $30 | $511.5K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 88 | 100 | 290 | $120 | $356.6K |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 39 | 60 | 200 | $120 | $310K |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 18 | 40 | 520 | $40 | $303.2K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 5 | 20 | 3,930 | $60 | $276K |
Showing 1–10 of 271
Other providers in the same ZIP code as System Coordinated Services, Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.